These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 22609283

  • 1. Phase behavior and oral bioavailability of amorphous Curcumin.
    Pawar YB, Shete G, Popat D, Bansal AK.
    Eur J Pharm Sci; 2012 Aug 30; 47(1):56-64. PubMed ID: 22609283
    [Abstract] [Full Text] [Related]

  • 2. Effect of counterions on the properties of amorphous atorvastatin salts.
    Sonje VM, Kumar L, Puri V, Kohli G, Kaushal AM, Bansal AK.
    Eur J Pharm Sci; 2011 Nov 20; 44(4):462-70. PubMed ID: 21907794
    [Abstract] [Full Text] [Related]

  • 3. Preparation and enhancement of oral bioavailability of curcumin using microemulsions vehicle.
    Hu L, Jia Y, Niu F, Jia Z, Yang X, Jiao K.
    J Agric Food Chem; 2012 Jul 25; 60(29):7137-41. PubMed ID: 22587560
    [Abstract] [Full Text] [Related]

  • 4. Phase transformations undergone by Triton X-100 probed by differential scanning calorimetry and dielectric relaxation spectroscopy.
    Merino EG, Rodrigues C, Viciosa MT, Melo C, Sotomayor J, Dionísio M, Correia NT.
    J Phys Chem B; 2011 Nov 03; 115(43):12336-47. PubMed ID: 21928821
    [Abstract] [Full Text] [Related]

  • 5. Novel lipid based oral formulation of curcumin: development and optimization by design of experiments approach.
    Pawar YB, Purohit H, Valicherla GR, Munjal B, Lale SV, Patel SB, Bansal AK.
    Int J Pharm; 2012 Oct 15; 436(1-2):617-23. PubMed ID: 22842624
    [Abstract] [Full Text] [Related]

  • 6. Comparative oral bioavailability advantage from curcumin formulations.
    Munjal B, Pawar YB, Patel SB, Bansal AK.
    Drug Deliv Transl Res; 2011 Aug 15; 1(4):322-31. PubMed ID: 25788366
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems.
    Cui J, Yu B, Zhao Y, Zhu W, Li H, Lou H, Zhai G.
    Int J Pharm; 2009 Apr 17; 371(1-2):148-55. PubMed ID: 19124065
    [Abstract] [Full Text] [Related]

  • 8. A comparative assessment of solubility advantage from glassy and crystalline forms of a water-insoluble drug.
    Chawla G, Bansal AK.
    Eur J Pharm Sci; 2007 Sep 17; 32(1):45-57. PubMed ID: 17618092
    [Abstract] [Full Text] [Related]

  • 9. Physical stability and solubility advantage from amorphous celecoxib: the role of thermodynamic quantities and molecular mobility.
    Gupta P, Chawla G, Bansal AK.
    Mol Pharm; 2004 Sep 17; 1(6):406-13. PubMed ID: 16028352
    [Abstract] [Full Text] [Related]

  • 10. Temperature-dependent spectroscopic evidences of curcumin in aqueous medium: a mechanistic study of its solubility and stability.
    Jagannathan R, Abraham PM, Poddar P.
    J Phys Chem B; 2012 Dec 20; 116(50):14533-40. PubMed ID: 23194397
    [Abstract] [Full Text] [Related]

  • 11. Enhanced bioavailability of a poorly soluble VR1 antagonist using an amorphous solid dispersion approach: a case study.
    Kennedy M, Hu J, Gao P, Li L, Ali-Reynolds A, Chal B, Gupta V, Ma C, Mahajan N, Akrami A, Surapaneni S.
    Mol Pharm; 2008 Dec 20; 5(6):981-93. PubMed ID: 19434920
    [Abstract] [Full Text] [Related]

  • 12. Glass transition and time-dependent crystallization behavior of dehydration bioprotectant sugars.
    Schebor C, Mazzobre MF, Buera Mdel P.
    Carbohydr Res; 2010 Jan 26; 345(2):303-8. PubMed ID: 19962131
    [Abstract] [Full Text] [Related]

  • 13. Thermodynamic behavior of glassy state of structurally related compounds.
    Kaushal AM, Bansal AK.
    Eur J Pharm Biopharm; 2008 Aug 26; 69(3):1067-76. PubMed ID: 18420396
    [Abstract] [Full Text] [Related]

  • 14. Enhanced oral bioavailability and antiasthmatic efficacy of curcumin using redispersible dry emulsion.
    Jang DJ, Kim ST, Oh E, Lee K.
    Biomed Mater Eng; 2014 Aug 26; 24(1):917-30. PubMed ID: 24211980
    [Abstract] [Full Text] [Related]

  • 15. Crystallization rate of amorphous nifedipine analogues unrelated to the glass transition temperature.
    Miyazaki T, Yoshioka S, Aso Y, Kawanishi T.
    Int J Pharm; 2007 May 04; 336(1):191-5. PubMed ID: 17184940
    [Abstract] [Full Text] [Related]

  • 16. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms.
    Xie X, Tao Q, Zou Y, Zhang F, Guo M, Wang Y, Wang H, Zhou Q, Yu S.
    J Agric Food Chem; 2011 Sep 14; 59(17):9280-9. PubMed ID: 21797282
    [Abstract] [Full Text] [Related]

  • 17. Investigations on the effect of different cooling rates on the stability of amorphous indomethacin.
    Karmwar P, Boetker JP, Graeser KA, Strachan CJ, Rantanen J, Rades T.
    Eur J Pharm Sci; 2011 Oct 09; 44(3):341-50. PubMed ID: 21884789
    [Abstract] [Full Text] [Related]

  • 18. Enhancement of oral bioavailability of an HIV-attachment inhibitor by nanosizing and amorphous formulation approaches.
    Fakes MG, Vakkalagadda BJ, Qian F, Desikan S, Gandhi RB, Lai C, Hsieh A, Franchini MK, Toale H, Brown J.
    Int J Pharm; 2009 Mar 31; 370(1-2):167-74. PubMed ID: 19100319
    [Abstract] [Full Text] [Related]

  • 19. Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers.
    Kanai M, Imaizumi A, Otsuka Y, Sasaki H, Hashiguchi M, Tsujiko K, Matsumoto S, Ishiguro H, Chiba T.
    Cancer Chemother Pharmacol; 2012 Jan 31; 69(1):65-70. PubMed ID: 21603867
    [Abstract] [Full Text] [Related]

  • 20. Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats.
    Setthacheewakul S, Mahattanadul S, Phadoongsombut N, Pichayakorn W, Wiwattanapatapee R.
    Eur J Pharm Biopharm; 2010 Nov 31; 76(3):475-85. PubMed ID: 20659556
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.